Duplication of the Antistasin-Like Structure Resulted in a New Anticoagulant Protein in the Medicinal Leech
Biomolecules · 2026
DOI: 10.3390/biom16010155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Ksenia A Brovina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genetic Reprogramming and Gene Therapy, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Bio…. Hauptthemen laut MEDLINE: Anticoagulants, Hirudo medicinalis, Leeches, Invertebrate Hormones. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Blood-sucking organisms produce various anticoagulant proteins that prevent blood clotting in their prey. Even in well-studied species like Hirudo medicinalis, many such proteins remain unidentified. We previously described a novel cysteine-rich anticoagulant (CRA), a distant homolog of antistasin. Later, we discovered another, much larger homolog in the medicinal leech. Its amino acid sequence is also highly cysteine-rich. Analysis of cysteine patterns showed four antistasin-like domain motifs, with one of them strongly disrupted. Since both antistasin and CRA contain two such domains, the new protein represents a duplicated antistasin-like structure. We cloned its cDNA, expressed the recombinant protein in Escherichia coli, purified it by metal-chelate chromatography, refolded it, and tested its anticoagulant properties. Using standard clinical assays—activated partial thromboplastin time, prothrombin time, and thrombin time—we found that the protein inhibited coagulation in all tests, though to varying degrees. These findings suggest that different antistasin-like anticoagulants in the leech enable it to block both intrinsic and extrinsic coagulation pathways, while hirudin inhibits the final step of clot formation. The combination of different anticoagulant proteins allows the leech to effectively prevent the prey’s blood from clotting during feeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Genetic Reprogramming and Gene Therapy, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya, 1a, 119435 Moscow, Russia.
- Moscow Center for Advanced Studies, 20, Kulakova Str., 123592 Moscow, Russia.
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya, 1a, 119435 Moscow, Russia.
ORCID-Profile: Ksenia A Brovina, Vladislav V Babenko, Valentin A Manuvera, Pavel A Bobrovsky, Daria D Kharlampieva, Vassili N Lazarev
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Brovina, K. A., Babenko, V. V., Manuvera, V. A., Bobrovsky, P. A., Kharlampieva, D. D., & Lazarev, V. N. (2026). Duplication of the Antistasin-Like Structure Resulted in a New Anticoagulant Protein in the Medicinal Leech. Biomolecules. https://doi.org/10.3390/biom16010155
Vancouver
Brovina KA, Babenko VV, Manuvera VA, Bobrovsky PA, Kharlampieva DD, Lazarev VN. Duplication of the Antistasin-Like Structure Resulted in a New Anticoagulant Protein in the Medicinal Leech. Biomolecules. 2026. doi:10.3390/biom16010155
BibTeX
@article{Brovina2026,
author = {Brovina, Ksenia A and Babenko, Vladislav V and Manuvera, Valentin A and Bobrovsky, Pavel A and Kharlampieva, Daria D and Lazarev, Vassili N},
title = {Duplication of the Antistasin-Like Structure Resulted in a New Anticoagulant Protein in the Medicinal Leech},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16010155}
}
EUVIMED